Atrial Tachycardia as a Predictor of Atrial Fibrillation, Stroke and Mortality in Cryptogenic Stroke
1 other identifier
observational
210
1 country
1
Brief Summary
There is few information about the association between supraventricular arrhythmia different from atrial fibrillation (AF) or atrial Flutter and the risk of stroke. In this study the investigators hypothesized that the presence of atrial tachycardia would lead to atrial fibrillation and recurrent stroke in patients hospitalized for cryptogenic stroke. The investigators study the association of atrial tachycardia (AT), defined as four or more consecutive premature atrial beats, and AF, recurrent stroke and cardiovascular mortality in 192 consecutive patients hospitalized because of cryptogenic stroke. The follow-up was 12 months for all population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 23, 2015
CompletedFirst Posted
Study publicly available on registry
February 27, 2015
CompletedFebruary 27, 2015
February 1, 2015
1 month
February 23, 2015
February 26, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
ischemic stroke
12 months
Secondary Outcomes (3)
atrial fibrillation
12 months
cardiovascular mortality
12 months
global mortality
12 months
Study Arms (2)
atrial tachycardia group
Patients diagnosed of cryptogenic stroke with atrial tachycardia in holter
Non atrial tachycardia group (control group)
Patients diagnosed of cryptogenic stroke with a normal holter
Interventions
Eligibility Criteria
We review all consecutive patients that were hospitalized from stroke in our hospital (Neurology department) between January 2010 and September 2013, and who had the diagnosis of cryptogenic stroke at discharge
You may qualify if:
- All consecutive patients that were hospitalized from stroke in our hospital (Neurology department) between January 2010 and September 2013, and who had the diagnosis of cryptogenic stroke at discharge
You may not qualify if:
- Patients with non-cryptogenic stroke
- Patients with haemorragic stroke
- Patients with terminal disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corporacio Sanitaria Parc Tauli
Sabadell, Barcelona, 08202, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph
Study Record Dates
First Submitted
February 23, 2015
First Posted
February 27, 2015
Study Start
January 1, 2015
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
February 27, 2015
Record last verified: 2015-02